牧原股份 reported revenue of ¥59.41B for the period ended 2026-06-30, -22.3% year on year. Net income was ¥-6.08B, a -10.2% net margin on a -1.6% gross margin. The largest revenue line is 生猪 at 88% of the total. Free cash flow for the period was ¥-3.33B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥59.41B | -22.3% |
| Gross profit | ¥-0.94B | — |
| Operating income | ¥-5.39B | — |
| Net income | ¥-6.08B | -156.4% |
| Gross margin | -1.6% | Net margin -10.2% |
| Revenue Q/Q | -1.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| 生猪 | ¥52.43B | 88.3% |
| 屠宰、肉食产品 | ¥22.06B | 37.1% |
| 饲料原料 | ¥4.32B | 7.3% |
| 其他主营业务 | ¥1.64B | 2.8% |
| 减:养殖与屠宰、肉食之间销售抵消 | ¥-21.04B | -35.4% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥60.35B | 101.6% |
| R&D | ¥0.71B | 1.2% |
| SG&A | ¥2.42B | 4.1% |
| Tax & other | ¥0.70B | 1.2% |
| Item | Amount |
|---|---|
| Total assets | ¥175.06B |
| Total liabilities | ¥94.85B |
| Shareholders' equity | ¥80.22B |
| Equity / assets | 45.8% |
| Operating cash flow | ¥-1.30B |
| Capital expenditure | ¥2.03B |
| Free cash flow | ¥-3.33B |
| Cash conversion (OCF / net income) | 37% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
国信证券 ・ 英维克 ・ 深南电路 ・ 德赛西威 ・ 鹏鼎控股 ・ 中国广核 ・ 亿纬锂能 ・ 爱尔眼科 ・ 同花顺 ・ 东方财富 ・ 智飞生物 ・ 汇川技术
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies